Proteomics

Dataset Information

0

SKBR3/HER2+ Breast Cancer Cellular Response to Lapatinib and Ipatasertib Kinase Inhibitors


ABSTRACT: To explore the broader impact of kinase inhibitors on breast cancer cells, SKBR3/HER2+ cells were treated with two small molecule drugs, i.e., Lapatinib (10 uM) - a Tyr kinase inhibitor, and Ipatasertib (1 uM) - a Ser/Thr kinase inhibitor. Serum-starved cells (24 h) were exposed for 36 h to Lapatinib/EGF or a combination of Lapatinib/Ipatasertib/EGF. EGF - only stimulated cells were used as control. The EGF concentration was 10 nM throughout all experiments. Proteomic profiles of nuclear and cytoplasmic cell fractions of treated vs non-treated cells were generated by nano-LC-MS/MS using an Orbitrap QE instrument.

INSTRUMENT(S): Q Exactive

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell

DISEASE(S): Breast Cancer

SUBMITTER: Iulia M. Lazar  

LAB HEAD: Iulia Lazar

PROVIDER: PXD051094 | Pride | 2024-08-23

REPOSITORIES: pride

Dataset's files

Source:
Action DRS
EGF_C_11.raw Raw
EGF_C_12.raw Raw
EGF_C_13.raw Raw
EGF_C_21.raw Raw
EGF_C_22.raw Raw
Items per page:
1 - 5 of 72

Similar Datasets

2011-09-19 | E-GEOD-16179 | biostudies-arrayexpress
2024-09-26 | PXD054180 | Pride
2016-06-15 | E-GEOD-81546 | biostudies-arrayexpress
2016-07-28 | E-GEOD-84896 | biostudies-arrayexpress
2012-05-18 | E-GEOD-37089 | biostudies-arrayexpress
2016-06-15 | GSE81651 | GEO
2016-06-15 | GSE81546 | GEO
2024-08-27 | PXD046330 | Pride
2016-06-15 | E-GEOD-81651 | biostudies-arrayexpress
2020-10-19 | GSE127988 | GEO